Ciongoli Gregory Austin
SEC insider (Form 3/4/5 filer). CIK 0002023732. Director at Gossamer Bio, Inc. (GOSS) and 3 other issuers. 9 reported Form 4/5 transactions since Sep 2024; latest on Sep 23, 2026. Located in SAN DIEGO, CA.
Companies Ciongoli Gregory Austin has filed insider reports for
- Gossamer Bio, Inc. (GOSS): Director
- REGENXBIO Inc. (RGNX): Director
- Atara Biotherapeutics, Inc. (ATRA): Director, 10% Owner
- Zymeworks Inc. (ZYME): Director
Ciongoli Gregory Austin
CIK: 0002023732
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Sep 23, 2026GOSS
Gossamer Bio, Inc.
AwardDirectStock Option (Right to Buy)
30K shares- - Aug 27, 2026RGNX
REGENXBIO Inc.
PurchaseDirect53.4K shares at avg. $9.36$500K - Aug 26, 2026RGNX
REGENXBIO Inc.
PurchaseDirect49.2K shares at avg. $9.14$450K - Aug 25, 2026RGNX
REGENXBIO Inc.
AwardDirect15.4K shares- - Jun 9, 2026ATRA
Atara Biotherapeutics, Inc.
AwardDirect12K shares- - Jan 12, 2026ZYME
Zymeworks Inc.
AwardDirectStock Option (Right to Buy)
11.5K shares- - Jan 12, 2026ZYME
Zymeworks Inc.
AwardDirectRestricted Stock Unit
7.7K shares- - Aug 12, 2025ZYME
Zymeworks Inc.
AwardDirect415K shares at avg. $12.02$5.0M - Aug 11, 2025ZYME
Zymeworks Inc.
AwardDirectStock Option (Right to Buy)
62K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 23, 2026 |  GOSS Gossamer Bio, Inc. | Award Stock Option (Right to Buy) | 30,000 | - | - | Direct |
| Aug 27, 2026 |  RGNX REGENXBIO Inc. | Purchase | 53,407 | $9.36 | $499,676 | Direct |
| Aug 26, 2026 | RGNX REGENXBIO Inc. | Purchase | 49,196 | $9.14 | $449,706 | Direct |
| Aug 25, 2026 | RGNX REGENXBIO Inc. | Award | 15,432 | - | $0 | Direct |
| Jun 9, 2026 |  ATRA Atara Biotherapeutics, Inc. | Award | 12,000 | - | $0 | Direct |
| Jan 12, 2026 |  ZYME Zymeworks Inc. | Award Stock Option (Right to Buy) | 11,500 | - | - | Direct |
| Jan 12, 2026 | ZYME Zymeworks Inc. | Award Restricted Stock Unit | 7,700 | - | - | Direct |
| Aug 12, 2025 | ZYME Zymeworks Inc. | Award | 415,000 | $12.02 | $4,988,300 | Direct |
| Aug 11, 2025 | ZYME Zymeworks Inc. | Award Stock Option (Right to Buy) | 62,000 | - | - | Direct |
1-9 of 9 transactions